153 related articles for article (PubMed ID: 19944552)
1. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment.
van Gijn W; Krijnen P; Lemmens VE; den Dulk M; Putter H; van de Velde CJ
Eur J Surg Oncol; 2010 Apr; 36(4):340-4. PubMed ID: 19944552
[TBL] [Abstract][Full Text] [Related]
2. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
3. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy.
den Dulk M; Krijnen P; Marijnen CA; Rutten HJ; van de Poll-Franse LV; Putter H; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; Coebergh JW; van de Velde CJ
Eur J Cancer; 2008 Aug; 44(12):1710-6. PubMed ID: 18573654
[TBL] [Abstract][Full Text] [Related]
4. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.
Rutten H; den Dulk M; Lemmens V; Nieuwenhuijzen G; Krijnen P; Jansen-Landheer M; van de Poll Franse L; Coebergh JW; Martijn H; Marijnen C; van de Velde C
Eur J Cancer; 2007 Oct; 43(15):2295-300. PubMed ID: 17709242
[TBL] [Abstract][Full Text] [Related]
5. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
6. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
7. Does a rectal cancer of the upper third behave more like a colon or a rectal cancer?
Rosenberg R; Maak M; Schuster T; Becker K; Friess H; Gertler R
Dis Colon Rectum; 2010 May; 53(5):761-70. PubMed ID: 20389210
[TBL] [Abstract][Full Text] [Related]
8. Nationwide quality assurance of rectal cancer treatment.
Wibe A; Carlsen E; Dahl O; Tveit KM; Weedon-Fekjaer H; Hestvik UE; Wiig JN;
Colorectal Dis; 2006 Mar; 8(3):224-9. PubMed ID: 16466564
[TBL] [Abstract][Full Text] [Related]
9. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
10. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
[TBL] [Abstract][Full Text] [Related]
11. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW
Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731
[TBL] [Abstract][Full Text] [Related]
12. Improved survival after resectable non-cardia gastric cancer in The Netherlands: the importance of surgical training and quality control.
Krijnen P; den Dulk M; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; van de Velde CJ
Eur J Surg Oncol; 2009 Jul; 35(7):715-20. PubMed ID: 19144490
[TBL] [Abstract][Full Text] [Related]
13. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
[TBL] [Abstract][Full Text] [Related]
14. Quality of treatment in routine care in a population sample of rectal cancer patients.
Engel J; Kerr J; Eckel R; Günther B; Heiss M; Heitland W; Jauch KW; Siewert JR; Hölzel D
Acta Oncol; 2005; 44(1):65-74. PubMed ID: 15848908
[TBL] [Abstract][Full Text] [Related]
15. Improved survival in patients with rectal cancer: a population-based register study.
Dahlberg M; Påhlman L; Bergström R; Glimelius B
Br J Surg; 1998 Apr; 85(4):515-20. PubMed ID: 9607537
[TBL] [Abstract][Full Text] [Related]
16. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
17. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.
Folkesson J; Birgisson H; Pahlman L; Cedermark B; Glimelius B; Gunnarsson U
J Clin Oncol; 2005 Aug; 23(24):5644-50. PubMed ID: 16110023
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in cancer of the colon and rectum in Sweden.
Birgisson H; Talbäck M; Gunnarsson U; Påhlman L; Glimelius B
Eur J Surg Oncol; 2005 Oct; 31(8):845-53. PubMed ID: 15979269
[TBL] [Abstract][Full Text] [Related]
19. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention.
De Graaf EJ; Doornebosch PG; Tollenaar RA; Meershoek-Klein Kranenbarg E; de Boer AC; Bekkering FC; van de Velde CJ
Eur J Surg Oncol; 2009 Dec; 35(12):1280-5. PubMed ID: 19487099
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
